Medical News: Benefit of New Taxane Affirmed in Prostate CA - in Oncology/Hematology, Prostate Cancer from MedPage Today
Links shared publicly online about this topic.
- 835total visits
Medical News: Benefit of New Taxane Affirmed in Prostate CA - in Oncology/Hematology, Prostate Cancer from MedPage Today
The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.
View full resource at medpagetoday.com
Tags: Cancer, Chemotherapy, Prostate Cancer, Prostate, Men's Health, News, Jevtana, Medical
Most Recently Shared on October 2, 2010 at 2:53 pm By:
Benefit of New Taxane Affirmed in Metastatic Prostate CA (CME/CE) http://ow.ly/19eH6l
Also Shared By:
Medical News: Benefit of New Taxane Affirmed in Prostate CA - in Oncology/Hematology, Prostate Cancer from MedPage Today
medpagetoday.com — “The recently approved chemotherapy agent cabazitaxel (Jevtana) improves overall survival in metastatic, hormone-refractory prostate cancer resistant to docetaxel (Taxotere), researchers affirmed.” View full resource at medpagetoday.com
Most Recently Shared on September 30, 2010 at 11:48 pm By:
Drugs and Devices OW OW Health
Benefit of New Taxane Affirmed in Prostate CA: The recently approved chemotherapy agent cabazitaxel (Jevtana)... http://bit.ly/9CKzDI #drug
Advertisement
FightCancer
@FightCancer
Benefit of New Taxane Affirmed in Prostate CA (CME/CE) http://bit.ly/avKtBy
1 year ago...